Background and Update for S1602 “A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder Cancer-Reference-Cited by-同舟云学术

Background and Update for S1602 “A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder Cancer

Published:2018-07 Issue:4 Volume:4 Page:522-524
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Svatek Robert S.,Tangen Cathy,Delacroix Scott,Lowrance William,Lerner Seth P.

Publisher

Elsevier BV

Subject

Urology

Reference6 articles.

1. Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer;Biot;Sci Transl Med,2012

2. Purified protein derivative skin test prior to bacillus Calmette-Guerin therapy may have therapeutic impact in patients with nonmuscle invasive bladder cancer;Niwa;J Urol,2018

3. Human toxicology of BCG applied in cancer immunotherapy;Schwarzenberg;Cancer Immunol Immunother,1976

4. Efficacy of bacillus Calmette-Guerin strains for treatment of nonmuscle invasive bladder cancer: a systematic review and network meta-analysis;Boehm;J Urol,2017

5. Bacillus Calmette-Guerin strain differences have an impact on clinical outcome in bladder cancer immunotherapy;Rentsch;Eur Urol,2014

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging molecular therapies in the treatment of bladder cancer;Exploration of Targeted Anti-tumor Therapy;2024-08-29

2. Contemporary Treatment of NMIBC—Is It Time to Move on from BCG?;Journal of Clinical Medicine;2024-07-14

3. Systemic versus localized Bacillus Calmette Guérin immunotherapy of bladder cancer promotes an anti‐tumoral microenvironment: Novel role of trained immunity;International Journal of Cancer;2024-03-14

4. BCG as an Innovative Option for HCC Treatment: Repurposing and Mechanistic Insights;Advanced Science;2024-02-02

5. Carcinoma In Situ (CIS): Is There a Difference in Efficacy between Various BCG Strains? A Comprehensive Review of the Literature;Cancers;2024-01-05